Detailed Narrative
Plantation Division Faces Dual Headwinds
The Tea and Coffee divisions were severely impacted by both biological cycles and extreme weather. Tea production leaf was lower by 29%, resulting in sales of 41.7 lakh kilos compared to 62.46 lakh kilos in the previous year. Coffee production in Karnataka suffered a 30% to 40% crop loss due to 49% higher precipitation and the biennial 'off year' cycle, yielding only 424 metric tonnes against 722 metric tonnes previously.
Auto Component Segment Hit by Sectoral Slowdown
The Electromags division saw domestic sales drop to ₹85 crores and export sales to ₹14 crores. This 10.6% decline in total revenue to ₹99.57 crores was attributed to the marked slowdown in the automobile sector. While the division has released new products, management warned that their full revenue potential would not be realized in 2021 due to ongoing pandemic-related disruptions.
COVID-19 Operational Impact and Recovery
The pandemic forced shutdowns across operations in late March 2020. Tea plantations in Tamil Nadu resumed in phases from April, with normal attendance only by May. The auto manufacturing facilities were shut from April 20 to May 4, 2020. Dental products also saw a significant Q1 FY21 impact, with turnover dropping to ₹37 crores from ₹62 crores in the same period last year.
Strategic Focus on Exports and Cost Rationalization
Despite the pandemic, the Tea division showed some improvement in the same period due to cost rationalization. Management is implementing strategic measures including increasing the production of orthodox teas and upgrading factories for quality improvement. Export sales for tea registered a small improvement of 2%, now accounting for 26% of total sales.
Shareholder Concerns Over Tanzania Assets
A key point of contention during the AGM was the performance of the Tanzania operations. Shareholders pointed out that over 1,000 hectares of land produced only ₹3.13 crores in revenue. Chairman Nusli Wadia admitted that the company has not had much control over these operations in the past but claimed they are improving, promising a detailed written response from MD Ness Wadia.